US6048729A
(en)
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6899882B1
(en)
|
1989-03-24 |
2005-05-31 |
The Regents Of The University Of California |
Endothelial cell growth factor methods of isolation and expression
|
DE69030660T2
(de)
*
|
1989-03-24 |
1997-09-25 |
Univ California |
Endothelialer zellwachsfaktor, isolierung und expression
|
US20030114374A1
(en)
*
|
1989-05-12 |
2003-06-19 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US7300791B2
(en)
*
|
1989-05-12 |
2007-11-27 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
EP0399816B1
(de)
*
|
1989-05-24 |
1995-12-20 |
Merck & Co. Inc. |
Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors
|
US5726152A
(en)
*
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
EP0506477B1
(de)
*
|
1991-03-28 |
1999-06-23 |
Merck & Co. Inc. |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
US5514779A
(en)
*
|
1991-06-07 |
1996-05-07 |
Zeneca Limited |
Biocidal proteins from plants
|
AU2861692A
(en)
*
|
1991-10-18 |
1993-05-21 |
Beth Israel Hospital Association, The |
Vascular permeability factor targeted compounds
|
DE69233022T2
(de)
*
|
1991-11-04 |
2004-02-12 |
Genetics Institute, LLC, Cambridge |
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
|
PT101031B
(pt)
|
1991-11-05 |
2002-07-31 |
Transkaryotic Therapies Inc |
Processo para o fornecimento de proteinas por terapia genetica
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
DE69329031T2
(de)
*
|
1992-09-03 |
2001-03-22 |
Univ California |
Das dorsalgewebe beeinflussender faktor
|
BR9207175A
(pt)
*
|
1992-10-28 |
1995-12-12 |
Genentech Inc |
Composição contendo antagonista de fator de crescimento de célula endotelial vascular sequência aminoácida de anticorpo monoclonal polipeptídeo e método de tratamento de tumor em mamífero
|
JPH08508511A
(ja)
*
|
1993-04-29 |
1996-09-10 |
ワシントン・ユニバーシテイー |
副行循環の改善への血小板由来成長因子の使用
|
EP0706563B1
(de)
*
|
1993-06-29 |
2004-10-06 |
Chiron Corporation |
Verkürzter keratinocyten-wachstumsfaktor(kgf)mit erhöhter biologischer aktivität
|
WO1995006131A1
(en)
*
|
1993-08-23 |
1995-03-02 |
Monash University |
A method for the assay, prophylaxis and/or treatment of human disease conditions
|
US5464815A
(en)
*
|
1993-09-08 |
1995-11-07 |
Genentech, Inc. |
Inhibition of heparin-binding
|
DE59410132D1
(de)
*
|
1993-12-24 |
2002-07-11 |
Forssmann Wolf Georg |
Humanes zirkulierendes cytokin cc-1
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
US5840301A
(en)
*
|
1994-02-10 |
1998-11-24 |
Imclone Systems Incorporated |
Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
|
US6448077B1
(en)
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US5861499A
(en)
|
1994-02-10 |
1999-01-19 |
Imclone Systems Incorporated |
Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
US7186688B1
(en)
*
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US6734285B2
(en)
*
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7109308B1
(en)
*
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
DK0751992T3
(da)
*
|
1994-03-08 |
2006-03-06 |
Human Genome Sciences Inc |
Karendotelvækstfaktor 2
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
EP0769552A4
(de)
*
|
1994-06-27 |
1997-06-18 |
Toagosei Co Ltd |
'antisense'nukleinsäure-zusammensetzung
|
US6152141A
(en)
*
|
1994-07-28 |
2000-11-28 |
Heartport, Inc. |
Method for delivery of therapeutic agents to the heart
|
AU3374795A
(en)
*
|
1994-08-29 |
1996-03-22 |
Prizm Pharmaceuticals, Inc. |
Conjugates of vascular endothelial growth factor with targeted agents
|
US6451523B1
(en)
*
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
IL114615A0
(en)
*
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
ATE207536T1
(de)
*
|
1995-02-09 |
2001-11-15 |
Us Gov Health & Human Serv |
Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
|
US7232667B2
(en)
*
|
1995-02-14 |
2007-06-19 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 polynucleotides
|
US6077692A
(en)
|
1995-02-14 |
2000-06-20 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US6693077B1
(en)
|
1995-02-14 |
2004-02-17 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
DE69630442T2
(de)
*
|
1995-03-02 |
2004-08-19 |
Amrad Operations Pty. Ltd., Richmond |
Ein neuartiger wachstumsfaktor und eine genetische sequenz, die für diesen codiert
|
US7160991B1
(en)
*
|
1995-03-02 |
2007-01-09 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor polypeptides
|
IL117645A
(en)
*
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
JPH11503012A
(ja)
*
|
1995-03-30 |
1999-03-23 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
ヒトgタンパク質結合レセプター
|
US7427492B1
(en)
*
|
1995-06-05 |
2008-09-23 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human tumor necrosis factor receptor-like2
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
US20020150578A1
(en)
*
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
US20020026037A1
(en)
*
|
1995-06-06 |
2002-02-28 |
Jing-Shan Hu |
Vascular endothelial growth factor 3 antibodies
|
US6013483A
(en)
*
|
1995-06-07 |
2000-01-11 |
Human Genome Sciences, Inc. |
DNA encoding endothelial monocyte activating polypeptide III
|
US7423125B2
(en)
|
1995-08-01 |
2008-09-09 |
Vegenics Limited |
Antibodies to VEGF-C
|
DE69624925T2
(de)
*
|
1995-08-15 |
2003-09-04 |
Connetics Corp |
Verwendung von relaxin zur stimulierung der angiogenese
|
AU710696C
(en)
*
|
1995-09-08 |
2002-10-24 |
Genentech Inc. |
VEGF-related protein
|
US6329169B1
(en)
*
|
1995-09-29 |
2001-12-11 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding cytostatin II
|
ES2341864T3
(es)
*
|
1995-09-29 |
2010-06-29 |
Universita Degli Studi Di Siena |
Genes regulados y usos de los mismos.
|
ATE248912T1
(de)
*
|
1995-10-23 |
2003-09-15 |
Childrens Medical Center |
Therapeutische antiangiogenische zusammensetzungen und verfahren
|
US7393943B1
(en)
*
|
1995-12-08 |
2008-07-01 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a human chemotactic cytokine I
|
US7888466B2
(en)
*
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US7063958B1
(en)
*
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US7084252B1
(en)
*
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
WO1997026277A2
(en)
*
|
1996-01-22 |
1997-07-24 |
Creative Biomolecules, Inc. |
Morphogen analogs and methods for producing them
|
US20030185792A1
(en)
*
|
1996-01-22 |
2003-10-02 |
Curis, Inc. |
Morphogen analogs of bone morphogenic proteins
|
IL125756A
(en)
|
1996-02-15 |
2003-05-29 |
Biosense Inc |
Catheter for use in surgery
|
US7357927B2
(en)
*
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6713061B1
(en)
*
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6410268B1
(en)
*
|
1996-03-18 |
2002-06-25 |
Human Genome Sciences, Inc. |
Polynucleotides encoding chemokine alpha-3
|
US6443974B1
(en)
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
US20030129643A1
(en)
*
|
1996-08-23 |
2003-07-10 |
Human Genome Sciences, Inc. |
T1 receptor-like ligand I
|
ATE306546T1
(de)
*
|
1996-08-23 |
2005-10-15 |
Ludwig Inst Cancer Res |
Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d)
|
CA2235867A1
(en)
*
|
1996-08-27 |
1998-03-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Hematopoietic stem cell growth factor (scgf)
|
US6013780A
(en)
*
|
1996-09-06 |
2000-01-11 |
Technion Research & Development Co. Ltd. |
VEGF145 expression vectors
|
ATE343400T1
(de)
*
|
1996-09-24 |
2006-11-15 |
Merck & Co Inc |
Verbindungen zur hemmung der angiogenese durch gentherapie
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US6743422B1
(en)
|
1996-10-15 |
2004-06-01 |
Amgen, Inc. |
Keratinocyte growth factor-2 products
|
US20030144202A1
(en)
*
|
1996-10-15 |
2003-07-31 |
Amgen Inc. |
Uses of keratinocyte growth factor-2
|
US6998418B1
(en)
|
1996-11-05 |
2006-02-14 |
Gp Medical, Inc. |
Acellular biological material chemically treated with genipin
|
US20060171907A1
(en)
*
|
1996-11-21 |
2006-08-03 |
The Procter & Gamble Company |
Oral care compositions providing enhanced whitening and stain prevention
|
JP4138013B2
(ja)
*
|
1996-12-23 |
2008-08-20 |
イミュネックス・コーポレーション |
Tnfスーパーファミリーのメンバーであるnf−kappa bの受容体アクティベーターに対するリガンド
|
US20040013664A1
(en)
*
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
US7285267B2
(en)
*
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
CA2277925A1
(en)
*
|
1997-01-14 |
1998-07-16 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6.alpha. and 6.beta.
|
JP2001509029A
(ja)
*
|
1997-01-21 |
2001-07-10 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
ヒトタンパク質
|
US20030165467A1
(en)
*
|
1997-01-21 |
2003-09-04 |
Technion Research & Development Co., Ltd. |
Angiogenic factor and use thereof in treating cardiovascular disease
|
US20020155538A1
(en)
*
|
1997-01-23 |
2002-10-24 |
Incyte Pharmaceuticals, Inc. |
Novel endothelial growth factor
|
AU6267098A
(en)
*
|
1997-02-05 |
1998-08-25 |
Regents Of The University Of California, The |
Morphogenic proteins
|
US5968780A
(en)
*
|
1997-02-06 |
1999-10-19 |
Human Genome Sciences, Inc. |
Dendritic cell-derived growth factor
|
US6485942B1
(en)
|
1997-02-14 |
2002-11-26 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
|
US6395707B1
(en)
*
|
1997-02-14 |
2002-05-28 |
Genentech, Inc. |
Methods of treatment utilizing variants of vascular endothelial cell growth factor
|
US6951924B2
(en)
*
|
1997-03-14 |
2005-10-04 |
Human Genome Sciences, Inc. |
Antibodies against secreted protein HTEBYII
|
US20060084082A1
(en)
|
1997-03-07 |
2006-04-20 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
US7968689B2
(en)
*
|
1997-03-07 |
2011-06-28 |
Human Genome Sciences, Inc. |
Antibodies to HSDEK49 polypeptides
|
US7196164B2
(en)
*
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
WO1999035158A1
(en)
*
|
1998-01-07 |
1999-07-15 |
Human Genome Sciences, Inc. |
36 human secreted proteins
|
ATE296117T1
(de)
|
1997-03-07 |
2005-06-15 |
Wistar Inst |
Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben
|
US6541212B2
(en)
*
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US5935813A
(en)
*
|
1997-03-20 |
1999-08-10 |
Incyte Pharmaceuticals, Inc. |
Human pancreatitis-associated protein
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1998046249A1
(en)
*
|
1997-04-15 |
1998-10-22 |
Radix Organization, Inc. |
Method of treating gastrointestinal ulcers and compositions therefor
|
US7205381B2
(en)
*
|
1997-04-21 |
2007-04-17 |
Schering Corporation |
Mammalian cytokines; related reagents and methods
|
US7220557B2
(en)
*
|
1997-04-24 |
2007-05-22 |
Human Genome Sciences, Inc. |
METH1 polynucleotides
|
US20030166065A1
(en)
*
|
1997-04-24 |
2003-09-04 |
Human Genome Sciences, Inc. |
Novel integrin ligand ITGL-TSP
|
JP2002500509A
(ja)
*
|
1997-04-30 |
2002-01-08 |
エフ.ホフマン−ラ ロシュ アーゲー |
ラットst38.2ケモカイン
|
US6342369B1
(en)
*
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6506569B1
(en)
*
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
US6031155A
(en)
*
|
1997-06-05 |
2000-02-29 |
Cameron-Mills; Verena |
Arabinoxylan degradation
|
US20060223077A1
(en)
*
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
US5891674A
(en)
*
|
1997-06-19 |
1999-04-06 |
Incyte Pharmaceuticals, Inc. |
Insulin receptor tyrosine kinase substrate
|
EP0996725A1
(de)
*
|
1997-06-27 |
2000-05-03 |
Human Genome Sciences, Inc. |
Menschliches nk-3 verwandtes prostata-spezifiches gen -1
|
AU8586198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor, lefty-1
|
AU8591198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor-15
|
WO1999006443A1
(en)
*
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor, lefty-2
|
US6416973B1
(en)
*
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
US20020112251A1
(en)
*
|
1997-08-04 |
2002-08-15 |
Mccarthy Sean A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
FR2767135B1
(fr)
*
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
US6699672B1
(en)
*
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
US20030161823A1
(en)
*
|
1998-08-31 |
2003-08-28 |
Neta Ilan |
Therapeutic and cosmetic uses of heparanases
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US6482923B1
(en)
*
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
US6635443B1
(en)
|
1997-09-17 |
2003-10-21 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
|
US20030108983A1
(en)
*
|
1997-09-17 |
2003-06-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6849719B2
(en)
*
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
AU9096398A
(en)
*
|
1997-09-22 |
1999-04-12 |
Kurokawa, Kiyoshi |
Megsin protein
|
US7321023B2
(en)
*
|
1997-11-07 |
2008-01-22 |
Incyte Corporation |
SP16 protein
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
US6808890B2
(en)
*
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
US20060009633A9
(en)
*
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
JP2001523453A
(ja)
*
|
1997-11-13 |
2001-11-27 |
ジェンセット |
分泌タンパク質の伸長cDNA
|
US20060286639A1
(en)
*
|
1997-11-13 |
2006-12-21 |
Serono Genetics Institute S.A. |
Complementary DNAs encoding proteins with signal peptides
|
EP1032666A1
(de)
|
1997-11-22 |
2000-09-06 |
Hyseq, Inc. |
Protein mit egf-motif aus foetaler leber-milz cdna genbank
|
US20020132981A1
(en)
*
|
1997-12-03 |
2002-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1037982A1
(de)
*
|
1997-12-08 |
2000-09-27 |
Ontogeny, Inc. |
Menschliche patched gene und proteine, und entsprechende verwendungen
|
US6303770B1
(en)
*
|
1997-12-10 |
2001-10-16 |
Zymogenetics, Inc. |
Nucleic acids encoding mammalian alpha helical protein-1
|
US6869927B1
(en)
|
1997-12-22 |
2005-03-22 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
CN1283997A
(zh)
*
|
1997-12-22 |
2001-02-14 |
人类基因组科学公司 |
角质形成细胞生长因子-2制剂
|
US6703485B2
(en)
*
|
1997-12-23 |
2004-03-09 |
The Trustees Of Columbia University In The City Of New York |
Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
|
EP1054687B8
(de)
*
|
1997-12-24 |
2008-07-16 |
Vegenics Limited |
Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen
|
JPH11187884A
(ja)
*
|
1997-12-26 |
1999-07-13 |
Hsp Kenkyusho:Kk |
熱ショック転写因子結合蛋白質
|
US6297367B1
(en)
*
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
US20030170213A1
(en)
*
|
1998-01-23 |
2003-09-11 |
Marc F. Charette |
Methods and compositions for enhancing cognitive function using morphogenic proteins
|
US7722671B1
(en)
|
1998-01-27 |
2010-05-25 |
St. Jude Medical, Inc. |
Medical devices with associated growth factors
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
ES2293473T3
(es)
|
1998-02-05 |
2008-03-16 |
Biosense Webster, Inc. |
Administracion intracardiaca de farmaco.
|
IL137616A0
(en)
|
1998-02-06 |
2001-07-24 |
Collateral Therapeutics Inc |
Variants of vegf-a
|
US6706869B1
(en)
*
|
1998-02-11 |
2004-03-16 |
Wyeth |
Map kinase phosphatases and polynucleotides encoding them
|
US6395890B1
(en)
*
|
1998-02-20 |
2002-05-28 |
Zymogenetics, Inc. |
Nucleic acids encoding connective tissue growth factor homologs
|
US6054276A
(en)
|
1998-02-23 |
2000-04-25 |
Macevicz; Stephen C. |
DNA restriction site mapping
|
US7579160B2
(en)
*
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US20050026248A1
(en)
*
|
1998-03-26 |
2005-02-03 |
Hsueh Aaron J.W. |
Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions
|
DE19813774A1
(de)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
|
US6573095B1
(en)
*
|
1998-04-29 |
2003-06-03 |
Genesis Research & Development Corporation Limited |
Polynucleotides isolated from skin cells
|
KR20010043583A
(ko)
*
|
1998-05-14 |
2001-05-25 |
우에노 도시오 |
신규의 폴리펩티드, 그 폴리펩티드를 암호화하는 cDNA및 그 용도
|
US7256039B2
(en)
*
|
1998-05-15 |
2007-08-14 |
Genentech, Inc. |
PRO4405 nucleic acids
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
US20030003545A1
(en)
*
|
1998-05-29 |
2003-01-02 |
Reinhard Ebner |
Interleukins-21 and 22
|
AU4411499A
(en)
*
|
1998-06-05 |
1999-12-20 |
Human Genome Sciences, Inc. |
Connective tissue growth factor-4
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
HU226073B1
(en)
*
|
1998-07-14 |
2008-04-28 |
Janssen Pharmaceutica Nv |
Neurotrophic growth factor
|
US7067473B1
(en)
*
|
1998-07-14 |
2006-06-27 |
Janssen Pharmaceutica N.V. |
Neurotrophic growth factor
|
US20070014787A1
(en)
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
US20050048612A1
(en)
*
|
1998-07-28 |
2005-03-03 |
Incyte Corporation |
Human epidermal proteins HEP1-1 to HEP1-6
|
US6706951B1
(en)
*
|
1998-08-17 |
2004-03-16 |
Pioneer Hi-Bred International, Inc. |
Maize nucleic acid encoding a GDP-mannose pyrophosphorylase
|
AU5551599A
(en)
*
|
1998-08-20 |
2000-03-14 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods for altering an acetyl-coa metabolic pathway of a plant
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
AU5801099A
(en)
*
|
1998-09-02 |
2000-03-21 |
Millennium Pharmaceuticals, Inc. |
14926 receptor, a novel g-protein coupled receptor
|
IL141686A0
(en)
*
|
1998-09-09 |
2002-03-10 |
Scios Inc |
Methods of treating hypertension and compositions for use therein
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
EP1417971A3
(de)
*
|
1998-09-09 |
2004-06-30 |
Scios Inc. |
Verwendung eines angiogenen Faktors zur Behandlung von mikrovaskulären Angiopathien
|
EP1114155A2
(de)
*
|
1998-09-17 |
2001-07-11 |
Incyte Pharmaceuticals, Inc. |
Menschliche gpcr proteine
|
US6680380B1
(en)
*
|
1998-09-18 |
2004-01-20 |
Schering Corporation |
Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
|
WO2000018923A2
(en)
*
|
1998-09-30 |
2000-04-06 |
Millennium Pharmaceuticals, Inc. |
Slgp protein and nucleic acid molecule and uses therefor
|
US20040058355A1
(en)
*
|
1998-09-30 |
2004-03-25 |
Millennium Pharmaceuticals, Inc. |
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
|
US20030166550A1
(en)
|
1999-08-27 |
2003-09-04 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US6451303B1
(en)
*
|
1998-10-13 |
2002-09-17 |
Chiron Corporation |
Method of treating coronary artery disease by administering a recombinant FGF
|
US6440934B1
(en)
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20020072489A1
(en)
*
|
1998-10-13 |
2002-06-13 |
Whitehouse Martha J. |
Angiogenically effective unit dose of FGF-2 and method of use
|
EP1137656A4
(de)
*
|
1998-11-12 |
2003-08-06 |
Human Genome Sciences Inc |
31 human-sekretierte proteine
|
US6375680B1
(en)
|
1998-12-01 |
2002-04-23 |
St. Jude Medical, Inc. |
Substrates for forming synthetic tissues
|
JP2002532083A
(ja)
*
|
1998-12-17 |
2002-10-02 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
47個のヒト分泌タンパク質
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
JP2000189171A
(ja)
*
|
1998-12-25 |
2000-07-11 |
Banyu Pharmaceut Co Ltd |
新規なグアノシン三リン酸(gtp)結合タンパク質共役型のレセプタ―タンパク質
|
WO2000043520A2
(en)
*
|
1999-01-25 |
2000-07-27 |
University Of Florida |
Materials and methods for producing geminivirus resistant plants
|
WO2000046391A2
(en)
*
|
1999-02-02 |
2000-08-10 |
The Trustees Of Columbia University In The City Of New York |
Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
JP2002540763A
(ja)
*
|
1999-02-10 |
2002-12-03 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
33個のヒト分泌タンパク質
|
DE19906096A1
(de)
*
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6392126B1
(en)
*
|
1999-02-25 |
2002-05-21 |
Pioneer Hi-Bred International, Inc. |
Adenosine deaminase homologues and uses thereof
|
US7083793B2
(en)
*
|
1999-02-26 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Tango 243 polypeptides and uses thereof
|
US6406907B1
(en)
*
|
1999-02-26 |
2002-06-18 |
Iowa State University Research Foundation |
Bovine tumor necrosis factor receptor-1 and methods of use
|
EP1157118A4
(de)
*
|
1999-03-01 |
2002-07-17 |
Insight Strategy & Marketing |
POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
|
IL128852A0
(en)
*
|
1999-03-05 |
2000-01-31 |
Compugen Ltd |
Novel nucleic acid and amino acid sequences
|
US6783954B2
(en)
*
|
1999-03-05 |
2004-08-31 |
Compugen Ltd. |
VEGF nucleic acid and amino acid sequences
|
US7465785B2
(en)
*
|
1999-03-08 |
2008-12-16 |
Genentech, Inc. |
Polypeptide encoded by a nucleic acid over-expressed in melanoma
|
US6689866B1
(en)
*
|
1999-03-09 |
2004-02-10 |
Curagen Corporation |
Polynucleotides and proteins encoded thereby
|
US8410248B2
(en)
*
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US8133734B2
(en)
*
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
US6965012B1
(en)
*
|
1999-03-30 |
2005-11-15 |
Eli Lilly And Company |
Flint polypeptide analogs
|
WO2000061757A1
(en)
*
|
1999-04-12 |
2000-10-19 |
Genentech, Inc. |
Tumor necrosis factor homologs and nucleic acids encoding the same
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
WO2000064261A1
(en)
*
|
1999-04-26 |
2000-11-02 |
Ludwig Institute For Cancer Research |
Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
|
US6416758B1
(en)
|
1999-04-28 |
2002-07-09 |
Board Of Regents, The University Of Texax System |
Antibody conjugate kits for selectively inhibiting VEGF
|
KR20020011394A
(ko)
*
|
1999-04-30 |
2002-02-08 |
미야타 도시오 |
메그-3 단백질
|
WO2000068378A1
(en)
*
|
1999-05-06 |
2000-11-16 |
National Jewish Medical And Research Center |
Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
|
WO2000071713A1
(en)
*
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor variants
|
CA2374050A1
(en)
*
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor dimers
|
AU5045900A
(en)
*
|
1999-05-25 |
2000-12-12 |
Beth Israel Deaconess Medical Center |
Meth1 and meth2 polynucleotides and polypeptides
|
US20030207793A1
(en)
*
|
1999-05-26 |
2003-11-06 |
Conklin Darrell C. |
Secreted alpha-helical protein - 32
|
EP1206573A4
(de)
*
|
1999-06-07 |
2004-08-04 |
Human Genome Sciences Inc |
26 humane sekretionsproteine
|
US6781028B1
(en)
*
|
1999-06-14 |
2004-08-24 |
Exelixis, Inc. |
Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
|
US20030153050A1
(en)
*
|
1999-06-28 |
2003-08-14 |
Conklin Darrell C. |
Helical polypeptide zalpha29
|
US20030096355A1
(en)
*
|
1999-07-09 |
2003-05-22 |
Ke Zhang |
Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
|
US6951738B2
(en)
*
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
ATE449174T1
(de)
*
|
1999-07-23 |
2009-12-15 |
Kenji Kangawa |
Neue peptide
|
WO2001010891A2
(en)
*
|
1999-08-05 |
2001-02-15 |
Research Corporation Technologies, Inc. |
Il-16 antagonists
|
US20030134788A1
(en)
*
|
1999-08-12 |
2003-07-17 |
Baker Kevin P. |
Human tumor necrosis factor receptor TR16
|
US20040214783A1
(en)
*
|
2002-05-08 |
2004-10-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
NZ523206A
(en)
*
|
1999-08-31 |
2004-12-24 |
Genentech Inc |
Antibodies that bind to tumor gene sequences
|
US20030120037A1
(en)
*
|
1999-09-22 |
2003-06-26 |
Ji Ming Wang |
Utilization of FPRL1 as a functional receptor by serum amyloid a (SAA)
|
US6998239B1
(en)
*
|
1999-10-12 |
2006-02-14 |
Chemocentryx, Inc. |
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
|
USRE39849E1
(en)
|
1999-10-12 |
2007-09-18 |
Chemocentryx, Inc. |
Methods for identifying modulators of CCX CKR activity
|
EP1226170B1
(de)
*
|
1999-10-18 |
2008-07-30 |
Lexicon Pharmaceuticals, Inc. |
Menschliches chordin und polynukleotiden die dafür kodieren
|
US7459308B2
(en)
*
|
1999-10-21 |
2008-12-02 |
Arbor Vita Corporation |
Nucleic acid molecule encoding a CLASP-2 transmembrane protein
|
US6726718B1
(en)
|
1999-12-13 |
2004-04-27 |
St. Jude Medical, Inc. |
Medical articles prepared for cell adhesion
|
US7029857B1
(en)
*
|
1999-12-17 |
2006-04-18 |
H. Lundbeck A/S |
Processes for obtaining compounds employing SNORF72 receptors
|
JP2001211886A
(ja)
*
|
2000-02-07 |
2001-08-07 |
Japan Science & Technology Corp |
L−体及びd−体アミノ酸を輸送するナトリウム非依存性小型中性アミノ酸トランスポーター及びその遺伝子
|
EP1259544B1
(de)
*
|
2000-02-11 |
2011-08-24 |
Biogen Idec MA Inc. |
Heterologes polypeptid der tnf familie
|
AU3988401A
(en)
|
2000-02-25 |
2001-09-03 |
Ludwig Inst Cancer Res |
Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins
|
US20030165891A1
(en)
*
|
2000-02-29 |
2003-09-04 |
Millennium Pharmaceuticals, Inc. |
Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9 alpha2delta-4, 54414, and 53763 molecules and uses therefor
|
WO2001065927A1
(en)
*
|
2000-03-03 |
2001-09-13 |
University Of Utah Research Foundation |
Mass1 gene, a target for anticonvulsant drug development
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US20030119739A1
(en)
*
|
2000-03-29 |
2003-06-26 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
|
US7070946B2
(en)
*
|
2000-05-23 |
2006-07-04 |
Tanabe Seiyaku Co., Ltd. |
Bone metabolism related protein and gene thereof
|
NZ523157A
(en)
*
|
2000-05-31 |
2004-08-27 |
Ortho Mcneil Pharm Inc |
DNAs encoding mammalian histamine receptor of the H4 subtype
|
US20030059461A1
(en)
*
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
US7355019B2
(en)
*
|
2000-06-06 |
2008-04-08 |
Sibtech, Inc. |
Cysteine-containing peptide tag for site-specific conjugation of proteins
|
JP2004500882A
(ja)
*
|
2000-06-21 |
2004-01-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
G−タンパク質結合受容体
|
WO2002011769A1
(en)
*
|
2000-08-04 |
2002-02-14 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
AU2001283229A1
(en)
*
|
2000-08-07 |
2002-02-18 |
Zymogenetics Inc. |
Snake venom polypeptide zsnk1
|
CA2421588C
(en)
*
|
2000-09-05 |
2010-01-26 |
Amgen Inc. |
Tnf receptor-like molecules and uses thereof
|
US20040059098A1
(en)
*
|
2000-10-13 |
2004-03-25 |
Tang Y. Tom |
Egf motif protein, egfl6 materials and methods
|
US6489456B1
(en)
*
|
2000-10-27 |
2002-12-03 |
Pe Corporation (Ny) |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
GB0028971D0
(en)
*
|
2000-11-28 |
2001-01-10 |
Inpharmatica Ltd |
Novel proteins
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
US7026462B2
(en)
*
|
2000-12-07 |
2006-04-11 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
US20040072997A1
(en)
*
|
2000-12-20 |
2004-04-15 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
EP1357931A2
(de)
*
|
2001-01-08 |
2003-11-05 |
Human Genome Sciences, Inc. |
Keratinozyt-wachstumsfaktor-2
|
US20030180309A1
(en)
*
|
2001-01-08 |
2003-09-25 |
Baum Peter R. |
Human B7 polypeptides
|
US7442370B2
(en)
*
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
AU2002258394A1
(en)
*
|
2001-02-07 |
2002-09-12 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
EP1379268A1
(de)
*
|
2001-02-23 |
2004-01-14 |
Genetics Institute, LLC |
Knorpelbildendes potential von aus humanem knochenmark-abgeleiteten cd105+ zellen durch bmp
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
US7741049B2
(en)
*
|
2001-03-15 |
2010-06-22 |
Sumitomo Chemical Company, Limited |
Analysis of agonist-activity and antagonist-activity to cytokinin receptor
|
US6962971B2
(en)
*
|
2001-03-16 |
2005-11-08 |
The Regents Of The University Of California |
Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
|
JP2004525930A
(ja)
*
|
2001-03-23 |
2004-08-26 |
バイオファーム・ゲゼルシャフト・ツア・バイオテクノロジシェン・エントヴィックルング・フォン・ファーマカ・ミット・ベシュレンクテル・ハフツング |
皮膚関連疾患の治療及び診断のためのTGF−βスーパーファミリーのサイトカインの使用
|
WO2002083919A2
(en)
*
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
US20030027751A1
(en)
*
|
2001-04-10 |
2003-02-06 |
Genvec, Inc. |
VEGF fusion proteins
|
US7795218B2
(en)
*
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
US20050232921A1
(en)
*
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
AU2002256172A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
WO2002083849A2
(en)
*
|
2001-04-13 |
2002-10-24 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
DE60236646D1
(de)
*
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 Antikörper
|
US6660737B2
(en)
|
2001-05-04 |
2003-12-09 |
The Procter & Gamble Company |
Medicinal uses of hydrazones
|
US6878729B2
(en)
*
|
2001-05-04 |
2005-04-12 |
The Procter & Gamble Company |
Medicinal uses of dihydropyrazoles
|
GB0119015D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Cardiff |
A fusion protein
|
AU2002367997A1
(en)
*
|
2001-08-15 |
2003-12-19 |
Centre National De La Recherche Scientifique (Cnrs) |
Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
|
WO2003016505A2
(en)
*
|
2001-08-21 |
2003-02-27 |
Chiron Corporation |
Kgf polypeptide compositions
|
WO2003018752A2
(en)
*
|
2001-08-23 |
2003-03-06 |
The Wistar Institute Of Anatomy And Biology |
An organotypic intestinal culture and methods of use thereof
|
MXPA04001986A
(es)
*
|
2001-08-29 |
2004-06-07 |
Genentech Inc |
Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
|
US20050222070A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
US20040214766A1
(en)
*
|
2001-10-01 |
2004-10-28 |
Kari Alitalo |
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
WO2003033727A1
(fr)
*
|
2001-10-12 |
2003-04-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Procede de criblage d'un inhibiteur de la mort cellulaire
|
IL161361A0
(en)
*
|
2001-10-17 |
2004-09-27 |
Zymogenetics Inc |
Secreted protein, ztnf9
|
US7371258B2
(en)
*
|
2001-10-26 |
2008-05-13 |
St. Jude Medical, Inc. |
Valved prosthesis with porous substrate
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US20030093147A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Ogle Matthew F. |
Medical devices that stimulate growth factor production
|
US20050137130A1
(en)
*
|
2001-11-14 |
2005-06-23 |
Bodmer Mark W. |
Medical treatment
|
WO2003046147A2
(en)
*
|
2001-11-26 |
2003-06-05 |
Bristol-Myers Squibb Company |
Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
|
US20030104496A1
(en)
*
|
2001-11-30 |
2003-06-05 |
Cytokinetics, Inc. |
Novel motor protein of P. falciparum and methods for its use
|
US7795213B2
(en)
*
|
2001-12-13 |
2010-09-14 |
Posco |
Methods of contacting β amyloid protein with VEGF
|
US20030171556A1
(en)
*
|
2001-12-13 |
2003-09-11 |
Chi-Bom Chae |
Beta-amyloid binding factors and inhibitors thereof
|
CA2472927A1
(en)
*
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
US20040162237A1
(en)
*
|
2002-01-15 |
2004-08-19 |
Fox Niles Wayne |
Use of lp82 to treat body weight disorders
|
KR20030062789A
(ko)
*
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 sim2-btm 및 이것을포함하는 생명공학제품
|
KR20030062788A
(ko)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 mph1-btm 및 이것을포함하는 생명공학제품
|
WO2003066808A2
(en)
*
|
2002-01-23 |
2003-08-14 |
Texas Tech University |
Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
|
AU2003215548A1
(en)
*
|
2002-02-01 |
2003-09-02 |
Bayer Healthcare Ag |
Regulation of human hematopoietin receptor-like protein
|
GB0202906D0
(en)
*
|
2002-02-07 |
2002-03-27 |
Univ London |
Prevention of myocardial damage
|
AU2003214171A1
(en)
*
|
2002-03-12 |
2003-09-29 |
Harold Brem |
Method for treating diabetic ulcers
|
US20060263770A1
(en)
*
|
2002-03-22 |
2006-11-23 |
Marco Colonna |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
ES2286450T3
(es)
*
|
2002-03-28 |
2007-12-01 |
The Genetics Company Inc. |
Proteinas de regulacion del crecimiento.
|
SI1499729T1
(sl)
*
|
2002-04-18 |
2011-11-30 |
Yeda Res & Dev |
Derivati encima ki inducira nf-kappab njihova priprava in uporaba
|
WO2003091282A1
(fr)
*
|
2002-04-24 |
2003-11-06 |
Banyu Pharmaceutical Co., Ltd. |
Mutant a activite ordinaire du recepteur h3 de l'histamine et utilisation correspondante
|
US20030055221A1
(en)
*
|
2002-05-07 |
2003-03-20 |
Jirong Lu |
Stability of flint through o-linked glycosylation
|
EP1382613A1
(de)
*
|
2002-07-16 |
2004-01-21 |
Sumitomo Chemical Company, Limited |
Neues G Protein, kodierende Nukleotidsequenzen und Verwendung des Proteins
|
US7435419B2
(en)
*
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
EP1575416B1
(de)
|
2002-07-19 |
2013-10-02 |
Beth Israel Deaconess Medical Center |
Verfahren zur diagnose von präeklampsie
|
US7335362B2
(en)
*
|
2002-07-19 |
2008-02-26 |
Beth Israel Deaconess Medical Center |
Methods of treating pre-eclampsia or eclampsia
|
GB0219303D0
(en)
*
|
2002-08-19 |
2002-09-25 |
Ares Trading Sa |
Protein
|
JP2006515177A
(ja)
*
|
2002-09-10 |
2006-05-25 |
ロランティス リミテッド |
Notchリガンドタンパク質を含む医薬組成物及び医学的処置
|
MXPA05003869A
(es)
*
|
2002-10-08 |
2005-06-22 |
Ares Trading Sa |
El uso de citocina capaz de enlazarse a la proteina de union a interleucina-18, y de inhibir la actividad de una segunda citocina.
|
GB0223984D0
(en)
*
|
2002-10-15 |
2002-11-20 |
Novartis Forschungsstiftung |
Methods for detecting teneurin signalling and related screening methods
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
US20040120950A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Kari Alitalo |
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
|
US20040235747A1
(en)
*
|
2003-01-02 |
2004-11-25 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating and/or preventing autoimmune diseases
|
US20060276385A1
(en)
*
|
2003-01-13 |
2006-12-07 |
Hanjoong Jo |
Anti-inflammatory agents and methods of their use
|
CA2514986A1
(en)
*
|
2003-02-05 |
2004-08-19 |
Applied Research Systems Ars Holding N.V. |
Mucin-like polypeptides
|
US7736646B2
(en)
*
|
2003-03-12 |
2010-06-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Methods for modulating angiogenesis with apelin compositions
|
US7084246B2
(en)
*
|
2003-04-17 |
2006-08-01 |
Molecular Logix, Inc. |
Epidermal growth factor agonists
|
ES2328640T3
(es)
|
2003-04-18 |
2009-11-16 |
Biogen Idec Ma Inc. |
Neublastina conjugada con un polimero glicosilada.
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
WO2005110009A2
(en)
*
|
2003-07-22 |
2005-11-24 |
Immunex Corporation |
COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
CN102813923B
(zh)
*
|
2003-08-27 |
2015-04-01 |
奥普索特克公司 |
用于治疗眼新血管疾病的组合治疗
|
AU2004269927B2
(en)
*
|
2003-09-08 |
2009-09-17 |
Merck Serono Sa |
Treatment of fibrotic disease
|
EP1672062B1
(de)
*
|
2003-09-11 |
2012-05-09 |
Hubit Genomix, Inc. |
Verfahren und kit zum nachweis von sklerose verursachenden proliferativen erkrankungen und/oder heilmittel gegen sklerose verursachende proliferative erkrankungen sowie verfahren und kit zur identifizierung einer bei der vorbeugung und/oder behandlung von sklerose verursachenden proliferativen erkrankungen wirksamen substanz
|
EA010650B1
(ru)
*
|
2003-09-29 |
2008-10-30 |
Уоррен Фармасьютикалз, Инк. |
Защищающие ткань цитокины для лечения и профилактики сепсиса и образования спаек
|
US20060104978A1
(en)
*
|
2003-10-24 |
2006-05-18 |
Ludwig Institute For Cancer Research |
Methods and compositions for PDGF-C activation and inhibition
|
WO2005047327A2
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
EP1699824A2
(de)
*
|
2003-12-16 |
2006-09-13 |
ZymoGenetics, Inc. |
Ztnf 12, ein tumornekrosefaktor
|
WO2005063820A2
(en)
*
|
2003-12-30 |
2005-07-14 |
Merck Patent Gmbh |
Il-7 fusion proteins
|
US20050176073A1
(en)
*
|
2004-02-06 |
2005-08-11 |
Chemocentryx, Inc. |
Cell proliferation associated with CCX CKR expression
|
JP2007536251A
(ja)
*
|
2004-05-04 |
2007-12-13 |
チルドレンズ メディカル センター コーポレーション |
子癇前症の処置のための方法および組成物
|
EP1612892B1
(de)
*
|
2004-06-30 |
2008-03-19 |
Tyco Electronics Nederland B.V. |
Verbinder für elektronische Bauteile
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
KR20070085227A
(ko)
*
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
|
SE0402025D0
(sv)
*
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
BRPI0514343A
(pt)
*
|
2004-08-13 |
2008-06-10 |
Anormed Inc |
combinações de quimiocinas para mobilizar células progenitoras/tronco
|
CN101123978B
(zh)
|
2004-08-19 |
2012-12-12 |
比奥根艾迪克Ma公司 |
神经胚素变体
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
PT1786454E
(pt)
*
|
2004-08-19 |
2010-08-18 |
Biogen Idec Inc |
Variantes de neublastina
|
US20070166281A1
(en)
*
|
2004-08-21 |
2007-07-19 |
Kosak Kenneth M |
Chloroquine coupled antibodies and other proteins with methods for their synthesis
|
US20080171033A1
(en)
*
|
2004-08-26 |
2008-07-17 |
Chiwen Chang |
Compositions and methods for treating diseases associated with angiogenesis and inflammation
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
AU2005286626B2
(en)
|
2004-09-24 |
2012-11-08 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
US20060090646A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Questair Technologies Inc. |
Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
CA2590671A1
(en)
|
2004-11-18 |
2006-05-26 |
Imclone Systems Incorporated |
Antibodies against vascular endothelial growth factor receptor-1
|
US20080026410A1
(en)
*
|
2004-12-02 |
2008-01-31 |
Antonia Vlahou |
Biomarkers for Bladder Cancer
|
KR20070092737A
(ko)
*
|
2004-12-15 |
2007-09-13 |
베스 이스라엘 데코니스 메디칼 센터 |
임신 합병증의 진단 및 치료에 유용한 핵산 및 폴리펩티드
|
KR20070100346A
(ko)
|
2005-01-05 |
2007-10-10 |
바이오겐 아이덱 엠에이 인코포레이티드 |
크립토 결합 분자
|
ATE553122T1
(de)
|
2005-02-28 |
2012-04-15 |
Sangamo Biosciences Inc |
Antiangiogene methoden und zusammensetzungen
|
WO2006097682A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Ucl Business Plc |
Mechano growth factor peptides and their use
|
BRPI0609439A2
(pt)
*
|
2005-03-23 |
2010-04-06 |
Wyeth Corp |
detecção de uma resposta imunológica a agentes moduladores de gdf-8
|
US7767789B2
(en)
*
|
2005-06-02 |
2010-08-03 |
University Hopitals of Cleveland |
Truncated proteins as cancer markers
|
US20060287234A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Genentech, Inc. |
Wound healing
|
JP2008547006A
(ja)
*
|
2005-06-17 |
2008-12-25 |
ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド |
変形性関節症のタンパク質プロフィール
|
WO2007024752A2
(en)
*
|
2005-08-26 |
2007-03-01 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
|
US7659250B2
(en)
*
|
2005-12-22 |
2010-02-09 |
Centocor, Inc. |
BMP-7 variant compositions, methods and uses
|
BRPI0621124A2
(pt)
|
2005-12-22 |
2011-11-29 |
Genentech Inc |
métodos para recuperação de uma proteìna de ligação à heparina
|
US20080064631A1
(en)
*
|
2006-01-13 |
2008-03-13 |
Jeffrey Molldrem |
T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
|
TWI501774B
(zh)
*
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP1993590B1
(de)
*
|
2006-03-01 |
2013-12-25 |
Biogen Idec MA Inc. |
Zusammensetzungen und verfahren zur verabreichung von proteinen der gdnf-liganden-familie
|
GB0604460D0
(en)
*
|
2006-03-06 |
2006-04-12 |
Isis Innovation |
Treatment
|
US9878003B2
(en)
|
2006-03-06 |
2018-01-30 |
The University Of Manchester |
Method of treating bone disorders using TSG-6
|
WO2007130619A1
(en)
*
|
2006-05-03 |
2007-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulating osteoclast differentiation, activation and bone resorption
|
ES2497641T3
(es)
|
2006-05-17 |
2014-09-23 |
The Ludwig Institute For Cancer Research |
Dirección a la regulación de VEGF-B de transportadores de ácidos grasos para modular enfermedades humanas
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
PL2046394T3
(pl)
*
|
2006-07-04 |
2015-05-29 |
Combigene Ab |
Zastosowanie sekwencji kwasów nukleinowych do leczenia chorób neurologicznych i psychiatrycznych, wektory i kompozycje
|
CN101506222B
(zh)
|
2006-07-14 |
2013-10-02 |
健泰科生物技术公司 |
重组蛋白的重折叠
|
AR062271A1
(es)
*
|
2006-08-07 |
2008-10-29 |
Genzyme Corp |
Uso de una cantidad efectiva de al menos un inhibidor de cxcr4, al menos un agonista de cxcr2 y g-csf para movilizar las celulas progenitoras y/o celulas madre
|
US8865169B2
(en)
*
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
US9023352B2
(en)
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
KR100984483B1
(ko)
*
|
2007-03-19 |
2010-10-01 |
(주)바이오니아 |
순환적 역전사 방법
|
EP2136778A2
(de)
*
|
2007-03-20 |
2009-12-30 |
Harold Brem |
Wachstumsfaktorvermittelte kosmezeutika und ihre verwendung zur verbesserung der hautqualität
|
US8673859B2
(en)
*
|
2007-03-20 |
2014-03-18 |
New York University |
GM-CSF cosmeceutical compositions and methods of use thereof
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
TWI445544B
(zh)
|
2007-05-01 |
2014-07-21 |
Biogen Idec Inc |
增進血管形成之組合物及方法
|
US20110135648A1
(en)
*
|
2007-08-08 |
2011-06-09 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
WO2009126698A2
(en)
*
|
2008-04-09 |
2009-10-15 |
Ludwig Institute For Cancer Research |
Regulation of fatty acid transporters
|
EP2310507A4
(de)
|
2008-07-08 |
2013-03-20 |
David Gladstone Inst |
Verfahren und zusammensetzungen zur angiogenesemodulierung
|
WO2010085606A1
(en)
*
|
2009-01-22 |
2010-07-29 |
Case Western Reserve University |
Protein biomarkers and therapeutic targets for osteoarthritis
|
EP3702001A1
(de)
|
2009-03-30 |
2020-09-02 |
Acceleron Pharma Inc. |
Bmp-alk3-antagonisten und ihre verwendung zur förderung des knochenwachstums
|
EP2427572B1
(de)
*
|
2009-05-01 |
2013-08-28 |
Illumina, Inc. |
Sequenzierungsverfahren
|
WO2011005298A2
(en)
*
|
2009-06-23 |
2011-01-13 |
The Regents Of The University Of California |
Enhancement of bmp retention
|
US9409983B2
(en)
*
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
CA2790203C
(en)
*
|
2010-02-19 |
2019-05-14 |
Norman Latov |
Inhibitor of macrophage scavenger receptor 1 (msr1) for the treatment of autoimmune demyelinating diseases
|
CN102770446B
(zh)
*
|
2010-02-26 |
2014-09-03 |
奥齿泰种植体股份有限公司 |
改善成骨细胞分化的寡肽
|
US20110218141A1
(en)
*
|
2010-03-03 |
2011-09-08 |
Hamrick Mark W |
Leptin therapy to increase muscle mass and to treat muscle wasting conditions
|
WO2011143538A1
(en)
|
2010-05-14 |
2011-11-17 |
Beth Israel Deaconess Medical Center |
Extracorporeal devices and methods of treating complications of pregnancy
|
JP2013530187A
(ja)
*
|
2010-06-17 |
2013-07-25 |
ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
炎症性疾患を治療するための組成物及び方法。
|
AU2011274423B2
(en)
|
2010-07-09 |
2016-02-11 |
Bioverativ Therapeutics Inc. |
Chimeric clotting factors
|
US20120171769A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Mcgonigle Joseph S |
Cell attachment coatings and methods
|
US9738707B2
(en)
|
2011-07-15 |
2017-08-22 |
Biogen Ma Inc. |
Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
|
US8507446B2
(en)
*
|
2011-08-09 |
2013-08-13 |
Mackay Memorial Hospital |
Use of PEDF-derived polypeptides for treating liver cirrhosis
|
DK2802606T3
(en)
|
2012-01-10 |
2018-06-25 |
Biogen Ma Inc |
INCREASE TRANSPORT OF THERAPEUTIC MOLECULES OVER THE BLOOD-BRAIN BARRIER
|
US9920295B2
(en)
*
|
2012-02-21 |
2018-03-20 |
The Trustees Of The University Of Pennsylvania |
Bioreactor for isolation of rare cells and methods of use
|
CA2862516C
(en)
|
2012-03-27 |
2023-02-14 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
US9133440B2
(en)
*
|
2012-09-27 |
2015-09-15 |
Claresa Levetan |
Generation of new pancreatic beta cells
|
WO2014120619A2
(en)
|
2013-01-30 |
2014-08-07 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use in treating metabolic disorders
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
SG11201505926VA
(en)
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
KR20220061248A
(ko)
|
2013-07-12 |
2022-05-12 |
이베릭 바이오, 인크. |
안과적 질환을 치료하거나 예방하기 위한 방법
|
EA201691306A1
(ru)
*
|
2013-12-23 |
2016-10-31 |
Альк-Абелло А/С |
Пептидные комбинации и их применение при лечении аллергии на клещей домашней пыли
|
EP3174894B1
(de)
|
2014-07-30 |
2021-06-23 |
NGM Biopharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
|
NZ730054A
(en)
|
2014-10-31 |
2023-11-24 |
Ngm Biopharmaceuticals Inc |
Compositions and methods of use for treating metabolic disorders
|
ES2893114T3
(es)
|
2015-02-04 |
2022-02-08 |
Bristol Myers Squibb Co |
Métodos para seleccionar moléculas terapéuticas
|
MX2017010066A
(es)
|
2015-02-04 |
2017-11-01 |
Hoffmann La Roche |
Oligomeros antisentido de tau y usos de los mismos.
|
EP3277815B1
(de)
|
2015-04-03 |
2021-09-22 |
University of Massachusetts |
Oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
|
EP3408391A4
(de)
|
2016-01-31 |
2019-08-28 |
University of Massachusetts |
Verzweigte oligonukleotide
|
CN109715206B
(zh)
|
2016-03-31 |
2023-11-07 |
恩格姆生物制药公司 |
结合蛋白及其使用方法
|
CA3033368A1
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
SG11202101288TA
(en)
|
2018-08-10 |
2021-03-30 |
Univ Massachusetts |
Modified oligonucleotides targeting snps
|
CA3174095A1
(en)
|
2021-06-23 |
2022-12-29 |
Vignesh Narayan HARIHARAN |
Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|